Normalization of CA-125 levels in patients with ovarian cancer undergoing intraperitoneal chemotherapy

被引：0
|
作者：
McBee, W. C. [1 ]
Richard, S. D. [1 ]
Seamon, L. G. [2 ,3 ]
Lesnock, J. [1 ]
O'Malley, D. M. [2 ,3 ]
Richardson, D. L. [2 ,3 ]
Krivak, T. C. [1 ]
机构：
[1] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Div Gynecol Oncol, Pittsburgh, PA 15213 USA
[2] Ohio State Univ, Arthur G James Canc Hosp, Div Gynecol Oncol, Columbus, OH 43210 USA
[3] Solove Res Inst, Columbus, OH USA
来源：
GYNECOLOGIC ONCOLOGY | 2009年 / 112卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
283
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [1] The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer
    Rocconi, Rodney P.
    Matthews, Kellie S.
    Kemper, Meredith K.
    Hoskins, Kelly E.
    Huh, Warner K.
    Straughn, J. Michael, Jr.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 114 (02) : 242 - 245
  • [2] CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
    Hegde, Mangala
    Chianeh, Yousef Rezaei
    Shetty, Jeevan
    Fernandes, Donald J.
    Rao, Pragna
    [J]. CUKUROVA MEDICAL JOURNAL, 2015, 40 (03): : 510 - 516
  • [3] Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
    Bernal-Bello, David
    Guerra-Perez, Ignacio
    Alegre-Zahonero, Laura
    [J]. BIOMEDICAL JOURNAL, 2022, 45 (05) : 847 - 848
  • [4] Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy Reply
    Chen, Wei-Chun
    Chang, Ting-Chang
    Chou, Hung-Hsueh
    [J]. BIOMEDICAL JOURNAL, 2022, 45 (05) : 849 - 850
  • [5] Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients
    Paulsen, T
    Marth, C
    Kærn, J
    Nustad, K
    Kristensen, GB
    Tropé, C
    [J]. GYNECOLOGIC ONCOLOGY, 2000, 76 (03) : 326 - 330
  • [6] Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels
    Kang, Sokbom
    Kim, Tae-Joong
    Seo, Sang-Soo
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Park, Sang-Yoon
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2011, 72 (01) : 50 - 54
  • [7] Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy
    Sabbatini, P.
    Mooney, D.
    Iasonos, A.
    Thaler, H.
    Aghajanian, C.
    Hensley, M.
    Konner, J.
    Spriggs, D.
    Abu-Rustum, N. R.
    Dupont, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 589 - 594
  • [8] SERUM CA-125 LEVELS AND SURGICAL FINDINGS IN PATIENTS UNDERGOING SECONDARY OPERATIONS FOR EPITHELIAL OVARIAN-CANCER
    RUBIN, SC
    HOSKINS, WJ
    HAKES, TB
    MARKMAN, M
    REICHMAN, BS
    CHAPMAN, D
    LEWIS, JL
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 160 (03) : 667 - 671
  • [9] IMMUNOSUPPRESSIVE ACIDIC PROTEIN AND CA-125 LEVELS IN PATIENTS WITH OVARIAN-CANCER
    CASTELLI, M
    BATTAGLIA, F
    SCAMBIA, G
    PANICI, PB
    FERRANDINA, G
    MILEO, AM
    MANCUSO, S
    FERRINI, U
    [J]. ONCOLOGY, 1991, 48 (01) : 13 - 17
  • [10] The Importance of the CA-125 Value in Patients with Ovarian cancer
    Bachmann, C.
    Bachmann, S.
    Grischke, E. M.
    Fehm, T.
    Wallwiener, D.
    Staebler, A.
    Solomayer, E. F.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 733 - 733
12345